Pant, S., Ducreux, M. P., Ikeda, M., Yu, X., O'Reilly, E. M., Trandafirescu, G., Viswanath, N., Mazzei, A., Macarulla, T. (2026). A phase 2/3 randomized study of BMS-986504 with nab-paclitaxel (nab-P) and gemcitabine (GEM) in first-line (1L) metastatic pancreatic ductal adenocarcinoma (PDAC) with homozygous
MTAP
deletion (
MTAP
-del): MountainTAP-30.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.tps796